Matthieu Marty

Matthieu Marty is a seasoned leader in clinical operations with over two decades of experience in the pharmaceutical industry. Currently serving as the Director of Clinical Portfolio Execution at CSL, Matthieu oversees resources in Europe and Australia as part of the Hematology Execution Team focusing on Sickle Cell Disease and Hereditary Hemochromatosis. Prior to this role, Matthieu held the position of Director, Clinical Trial Manager at Vifor Pharma, managing clinical trials and operations across Europe and China. Matthieu's extensive background includes senior roles at GSK Consumer Healthcare, Novartis Consumer Health, and Merck Serono, along with foundational experience at sanofi-aventis and MDS Pharma Services. Matthieu's educational background includes degrees in Data Management and Biomedical/Medical Engineering from institutions such as Université Pharmacie Montpellier and Oklahoma State University.